Waters Corporation

WAT Healthcare Diagnostics & Research

Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

436.95 7.20 −1.62%
Market cap
$43.6B
P/E
109×
Fwd P/E
44.3×
Dividend yield
—
F-score
5/9
Altman Z
9.63
Beneish M
−2.37
Dividend safety
n/a

Waters Corporation (WAT) Operating cash flow

Alert me on Operating cash flow

Waters Corporation's operating cash flow for fiscal 2025 was $652.6M, down 14.4% from $762.1M in fiscal 2024. Over the twelve months to 30 June 2026 it was $549.6M. Over the past ten years it has ranged from $573.2M (fiscal 2015) to $790.5M (fiscal 2020); the current reading is higher than 64% of that period. Waters Corporation ranks 15th of 52 Diagnostics & Research companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $652.6M (14.38%)
FY2024 $762.1M 26.43%
FY2023 $602.8M (1.45%)
FY2022 $611.7M (18.15%)
FY2021 $747.3M (5.47%)
FY2020 $790.5M 22.92%
FY2019 $643.1M 6.39%
FY2018 $604.4M (13.36%)
FY2017 $697.6M 8.51%
FY2016 $642.9M 12.15%

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $201.0M —
Mar 2026 −$3.0M —
Dec 2025 $164.6M (12.00%)
Sep 2025 $187.0M 356.10%
42 more quarters

Against its own ten years

Low $573.2M High $790.5M
Ten-year median $643.1M
Current reading's percentile 64

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on WAT